ABSTRACT
BACKGROUND: Eosinophilic esophagitis is an esophageal disorder characterized by esophageal and/or upper gastrointestinal tract symptoms, and by dense esophageal eosinophilia associated with a normal gastric and duodenal mucosa. Prevalently reported in children, eosinophilic esophagitis has recently been reported with increased frequency also in adults. AIMS: The purpose of this study was to report our experience with eosinophilic esophagitis in Italy, since there are only very few series of such patients in our country. PATIENTS AND METHODS: We retrospectively reviewed the histological data of consecutive patients with a diagnosis of esophagitis or reflux disease in the period September 2004-September 2008. Eosinophils were counted where they appeared most numerous in the biopsy, with a cutoff > 15 eosinophils in more than one high-power field as diagnostic of eosinophilic esophagitis. Patients were excluded if gastric or duodenal biopsies showed a prominent eosinophilic infiltrate. RESULTS: Twenty two patients (14 adults, 8 children, age range 2-59 years) were identified according to the above criteria. The average eosinophil count was 86/ high-power field (range 31-150), associated with other pathologic features (eosinophilic microabscesses eosinophil degranulation, basal zone hyperplasia, papillary elongation). The main clinical complaints were dysphagia, food impaction, and heartburn, and endoscopic findings consisted of mucosal thickening and inelasticity, longitudinal shearing, rings, and white specks, without difference between adults and children for both clinical and endoscopic variables. CONCLUSIONS: Eosinophilic esophagitis is not rare in Italy, and displays clinical, endoscopic, and pathologic features similar to those described in other countries.
Subject(s)
Eosinophilia/epidemiology , Esophagitis/epidemiology , Abscess/etiology , Abscess/pathology , Adolescent , Adult , Biopsy , Cell Degranulation , Child , Child, Preschool , Elasticity , Eosinophilia/immunology , Eosinophilia/pathology , Esophagitis/immunology , Esophagitis/pathology , Esophagoscopy , Female , Food Hypersensitivity/complications , Humans , Italy/epidemiology , Male , Middle Aged , Retrospective Studies , Young AdultABSTRACT
Background: eosinophilic esophagitis is an esophageal disorder characterized by esophageal and/or upper gastrointestinal tract symptoms, and by dense esophageal eosinophilia associated with a normal gastric and duodenal mucosa. Prevalently reported in children, eosinophilic esophagitis has recently been reported with increased frequency also in adults. Aims: the purpose of this study was to report our experience with eosinophilic esophagitis in Italy, since there are only very few series of such patients in our country. Patients and methods: we retrospectively reviewed the histological data of consecutive patients with a diagnosis of esophagitis or reflux disease in the period September 2004-September 2008. Eosinophils were counted where they appeared most numerous in the biopsy, with a cutoff > 15 eosinophils in more than one high-power field as diagnostic of eosinophilic esophagitis. Patients were excluded if gastric or duodenal biopsies showed a prominent eosinophilic infiltrate. Results: twenty two patients (14 adults, 8 children, age range 2-59 years) were identified according to the above criteria. The average eosinophil count was 86/ high-power field (range 31- 150), associated with other pathologic features (eosinophilic microabscesses eosinophil degranulation, basal zone hyperplasia, papillary elongation). The main clinical complaints were dysphagia, food impaction, and heartburn, and endoscopic findings consisted of mucosal thickening and inelasticity, longitudinal shearing, rings, and white specks, without difference between adults and children for both clinical and endoscopic variables. Conclusions: eosinophilic esophagitis is not rare in Italy, and displays clinical, endoscopic, and pathologic features similar to those described in other countries(AU)
Subject(s)
Humans , Male , Female , Child, Preschool , Child , Adolescent , Adult , Middle Aged , Esophagitis/complications , Esophagitis/epidemiology , Biopsy/methods , Proton Pumps/therapeutic use , Prednisone/therapeutic use , Deglutition Disorders/complications , Italy/epidemiology , Retrospective Studies , Endoscopy/methods , Endoscopy, Digestive System/instrumentationABSTRACT
BACKGROUND: Bloating is a fastidious symptom reported by many patients who also have other gastrointestinal functional disorders. Bloating is more common in women, and it is often associated with meals and improves or disappears overnight. No specific treatments are to date available for this disturbing symptom. AIMS: to evaluate the effects of an oral enterovaccine (Colifagina) on bloating and other abdominal symptoms in patients with prevalent complaints of functional bloating. PATIENTS AND METHODS: One hundred and forty-eight patients with functional bloating according to Rome III criteria were recruited. Questionnaires and a VAS scale on their symptoms were administered at baseline and after four weeks of therapy with Colifagina. RESULTS: After treatment, a significant amelioration of bloating (p < 0.0001), abdominal pain (p < 0.0001) and flatus (p < 0.0001) was observed; nausea and vomiting scores were not significantly different at the end of the treatment. Subjective wellbeing was also generally improved (p < 0.001) in treated patients. CONCLUSION: Treatment with an enterovaccine may help improve symptoms in patients with functional bloating.
Subject(s)
Adjuvants, Immunologic/therapeutic use , Bacteria/immunology , Bacterial Vaccines/therapeutic use , Flatulence/therapy , Probiotics/therapeutic use , Adolescent , Adult , Animals , Disease Models, Animal , Female , Flatulence/etiology , Humans , Interviews as Topic , Male , Mice , Middle Aged , Nausea/therapy , Pain Measurement , Statistics, Nonparametric , Surveys and Questionnaires , Treatment Outcome , Vomiting/therapyABSTRACT
Background: bloating is a fastidious symptom reported bymany patients who also have other gastrointestinal functional disorders.Bloating is more common in women, and it is often associatedwith meals and improves or disappears overnight. No specifictreatments are to date available for this disturbing symptom.Aims: to evaluate the effects of an oral enterovaccine (Colifagina®) on bloating and other abdominal symptoms in patients withprevalent complaints of functional bloating.Patients and methods: one hundred and forty-eight patientswith functional bloating according to Rome III criteria were recruited.Questionnaires and a VAS scale on their symptoms wereadministered at baseline and after four weeks of therapy with Colifagina®.Results: after treatment, a significant amelioration of bloating(p < 0.0001), abdominal pain (p < 0.0001) and flatus (p <0.0001) was observed; nausea and vomiting scores were not significantlydifferent at the end of the treatment. Subjective wellbeingwas also generally improved (p < 0.001) in treated patients.Conclusion: treatment with an enterovaccine may help improvesymptoms in patients with functional bloating(AU)
Subject(s)
Humans , Animals , Male , Female , Adolescent , Adult , Mice , Adjuvants, Immunologic/therapeutic use , Bacterial Vaccines/therapeutic use , Flatulence/etiology , Flatulence/therapy , Probiotics/therapeutic use , Vomiting/therapy , Disease Models, Animal , Interviews as Topic , Nausea/therapy , /methods , Surveys and Questionnaires , Statistics, Nonparametric , Treatment OutcomeABSTRACT
BACKGROUND: The colon shows frequent eosinophilic infiltration in allergic proctocolitis of infants, whereas in adults, eosinophilic infiltration of the colon is less defined and may be found in different conditions including drug-induced colitis, even though the pathological findings are often inconsistent. AIM: To quantify eosinophils in the mucosa of normal controls and to compare them with those of patients with abdominal symptoms related to 'drug colitis'. METHODS: Mucosal biopsies were obtained during colonoscopy in 15 controls and in 27 patients with abdominal symptoms, a history of probable 'drug-related colitis' and without obvious causes of eosinophilia. RESULTS: The drugs related to the patient symptoms were nonsteroidal anti-inflammatory drugs (70%), antiplatelet agents (19%) and oestroprogestinic agents (11%). Colonoscopy was normal in 30% of patients and abnormal in 70%. Histology showed low content of inflammatory cells and normal crypt architecture in-patients with endoscopy similar to inflammatory bowel diseases. The eosinophil score was significantly higher in the left side of the colon in the patient group compared with controls. CONCLUSIONS: The finding of an increased eosinophil count limited to the left (descending and sigmoid) colon is an important clue towards a diagnosis of drug-related colitis.